Home

Agricultural fingerprint Walter Cunningham evolve short dapt Frugal Wink pressure

Studying DAPT – SYNERGY Stent - Boston Scientific
Studying DAPT – SYNERGY Stent - Boston Scientific

EVOLVE Short DAPT: A Single-Arm Study of 3-Month DAPT in Patients at High  Bleeding Risk Treated With a Bioabsorbable Polymer-Based Everolimus-Eluting  Stent | tctmd.com
EVOLVE Short DAPT: A Single-Arm Study of 3-Month DAPT in Patients at High Bleeding Risk Treated With a Bioabsorbable Polymer-Based Everolimus-Eluting Stent | tctmd.com

Managing Anticoagulation and Dual Antiplatelet Therapy in Patients with  Active Bleed or Upcoming Procedure: A Scoping Review | Published in Journal  of Brown Hospital Medicine
Managing Anticoagulation and Dual Antiplatelet Therapy in Patients with Active Bleed or Upcoming Procedure: A Scoping Review | Published in Journal of Brown Hospital Medicine

JCM | Free Full-Text | Evolution of Coronary Stent Platforms: A Brief  Overview of Currently Used Drug-Eluting Stents
JCM | Free Full-Text | Evolution of Coronary Stent Platforms: A Brief Overview of Currently Used Drug-Eluting Stents

3- or 1-Month DAPT in Patients at High Bleeding Risk Undergoing  Everolimus-Eluting Stent Implantation
3- or 1-Month DAPT in Patients at High Bleeding Risk Undergoing Everolimus-Eluting Stent Implantation

EVOLVE Short DAPT in Print: P2Y12 Decisions Can Safely Be Made Case-by-Case  | tctmd.com
EVOLVE Short DAPT in Print: P2Y12 Decisions Can Safely Be Made Case-by-Case | tctmd.com

3- or 1-Month DAPT in Patients at High Bleeding Risk Undergoing  Everolimus-Eluting Stent Implantation - ScienceDirect
3- or 1-Month DAPT in Patients at High Bleeding Risk Undergoing Everolimus-Eluting Stent Implantation - ScienceDirect

Safe to Drop P2Y12 Inhibitor at 3 Months in High-Bleeding-Risk Patients: EVOLVE  Short DAPT | tctmd.com
Safe to Drop P2Y12 Inhibitor at 3 Months in High-Bleeding-Risk Patients: EVOLVE Short DAPT | tctmd.com

Session evaluation and key learnings
Session evaluation and key learnings

Evolving Concepts in Post-PCI Antiplatelets Therapy
Evolving Concepts in Post-PCI Antiplatelets Therapy

SAFETY OF ABBREVIATED DAPT IN HIGH BLEEDING RISK PATIENTS ON ANTICOAGULANTS  OR AGE ≥75 YEARS AFTER PCI WITH THE SYNERGY STENT: A SUBGROUP ANALYSIS OF  THE EVOLVE SHORT DAPT STUDY | Journal
SAFETY OF ABBREVIATED DAPT IN HIGH BLEEDING RISK PATIENTS ON ANTICOAGULANTS OR AGE ≥75 YEARS AFTER PCI WITH THE SYNERGY STENT: A SUBGROUP ANALYSIS OF THE EVOLVE SHORT DAPT STUDY | Journal

EVOLVE SHORT-DAPT: Three-Month Outcomes on Dual Antiplatelet Therapy in a  High Bleeding Risk Population Treated With a Bioresorbable Polymer-Based  Drug-Eluting Stent | tctmd.com
EVOLVE SHORT-DAPT: Three-Month Outcomes on Dual Antiplatelet Therapy in a High Bleeding Risk Population Treated With a Bioresorbable Polymer-Based Drug-Eluting Stent | tctmd.com

Three-month DAPT after PCI with Synergy stent supported in EVOLVE Short DAPT  trial - Cardiovascular News
Three-month DAPT after PCI with Synergy stent supported in EVOLVE Short DAPT trial - Cardiovascular News

Primary Results of the EVOLVE Short DAPT Study | Circulation:  Cardiovascular Interventions
Primary Results of the EVOLVE Short DAPT Study | Circulation: Cardiovascular Interventions

Antiplatelet therapy after percutaneous coronary intervention -  EuroIntervention
Antiplatelet therapy after percutaneous coronary intervention - EuroIntervention

Shortened dual antiplatelet therapy in contemporary percutaneous coronary  intervention era
Shortened dual antiplatelet therapy in contemporary percutaneous coronary intervention era

XIENCE Stent: Protecting Patients with Short DAPT Needs | Abbott
XIENCE Stent: Protecting Patients with Short DAPT Needs | Abbott

Short and Optimal DAPT: Lessons From the EVOLVE SHORT-DAPT Late Breaking  Science​ | tctmd.com
Short and Optimal DAPT: Lessons From the EVOLVE SHORT-DAPT Late Breaking Science​ | tctmd.com

EVOLVE & EVOLVE II Clinical Trial Results - Boston Scientific
EVOLVE & EVOLVE II Clinical Trial Results - Boston Scientific

EVOLVE Short DAPT with the SYNERGY BP Stent - YouTube
EVOLVE Short DAPT with the SYNERGY BP Stent - YouTube

SYNERGY EVOLVE Short DAPT Begins Enrollment - Boston Scientific
SYNERGY EVOLVE Short DAPT Begins Enrollment - Boston Scientific

Bleeding and Ischemic Risk Prediction in Patients With High Bleeding Risk  (an EVOLVE Short DAPT Analysis) - ScienceDirect
Bleeding and Ischemic Risk Prediction in Patients With High Bleeding Risk (an EVOLVE Short DAPT Analysis) - ScienceDirect

Strategies of IVUS-Guided Left Main PCI SYNERGY MEGATRON™ BP Stent
Strategies of IVUS-Guided Left Main PCI SYNERGY MEGATRON™ BP Stent